[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2550 Introduced in House (IH)]
<DOC>
117th CONGRESS
1st Session
H. R. 2550
To require GAO review of certain TSA screening protocols, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 15, 2021
Mr. Taylor (for himself and Miss Rice of New York) introduced the
following bill; which was referred to the Committee on Homeland
Security
_______________________________________________________________________
A BILL
To require GAO review of certain TSA screening protocols, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Traveling Parents Screening
Consistency Act of 2021''.
SEC. 2. COMPTROLLER GENERAL REVIEW.
Not later than 1 year after the date of the enactment of this Act,
the Comptroller General of the United States shall conduct a review of
the Transportation Security Administration's (TSA) implementation of
the Bottles and Breastfeeding Equipment Screening Act (Public Law 114-
293), as well as the effectiveness of TSA in ensuring screening
protocol clarity and screening consistency relating to the screening of
formula, breast milk, purified deionized water for infants, and juice.
Such review shall include the following:
(1) Consider whether TSA effectively manages consistency of
screening protocol applications for formula, breastmilk,
purified deionized water for infants, and juice.
(2) Evaluate the need for TSA to update and revise
procedures for such screening.
(3) Assess whether TSA effectively tracks passenger
complaints related to such screening to monitor trends and
identify inconsistencies.
(4) Evaluate TSA's communications and information sharing
practices for passengers, air carriers, and airports relating
to screening protocols for such screening.
(5) Evaluate TSA's policies regarding the screening of
passengers with nursing products, including the extent to which
such passengers are more likely to receive secondary screening.
(6) Make recommendations for improving TSA's overall
screening practices relating to such screening.
<all>